Where to Buy NAD+ Peptide Safely in 2026

Where can you buy NAD+ safely in 2026?
Start by correcting the label: NAD+ is a coenzyme, not a peptide, so treat “NAD+ peptide” listings as loose marketing and judge the seller the same careful way. For injectable NAD+, the safe channel has a clinician prescribe it and a named FDA-registered 503A pharmacy compound it. FormBlends is my first pick, with a physician reviewing you before any vial is made.
I write about longevity, and few molecules get searched as sloppily as this one. NAD+ stands for nicotinamide adenine dinucleotide, a coenzyme every cell uses for energy metabolism and DNA repair. It gets grouped with peptides like BPC-157 and sermorelin because the same clinics and the same grey-market vendors sell all of them side by side, often injectable and often unsupervised. That shared shelf is exactly why the sourcing question matters: an injectable you put under your skin should come from a licensed pharmacy with a prescriber attached, whatever the molecule is called.
So this is a buying guide, not a hype piece. The job is to lay out the routes a careful buyer would actually weigh, rank the real providers behind each one, and keep two facts in view the whole way: compounded NAD+ is not an FDA-approved drug, and the human evidence for injectable NAD+ as an anti-aging therapy is early and thin. A good source says both out loud rather than selling around them.
How I ranked these
Because the search intent here is where to buy and the molecule goes under the skin, I weighted clinical oversight and pharmacy compliance the heaviest, then honesty about FDA status, then pricing and continuity. A prescriber and a named pharmacy are what separate treatment from a chemical purchase.
- Is a licensed prescriber required first? A clinician who evaluates you before anything ships is the single largest difference between supervised care and a research vial.
- Does a specific 503A pharmacy own the compounding? An injectable belongs to one FDA-registered pharmacy held to USP-797 and cGMP, identified on the record, not a powder from an unnamed lab.
- Does the source tell the truth about approval? Compounded NAD+ is not FDA-approved, and the anti-aging evidence is preliminary. Stating both beats implying a clearance that does not exist.
- Is pricing open and shipping reliable? Posted prices and temperature-aware delivery matter for a product that has to arrive intact.
- Will the source last? A provider that can carry the rest of a protocol beats a single-product vendor that could vanish the way grey-market names have through 2025 and 2026.
The research-use-only sellers near the foot of this ranking are a different product class rather than dishonest ones, ranked on their genuine attributes, with documented facts noted where the record runs thin.
The ranking: 5 places to buy NAD+, best to least
1. FormBlends: 9.1/10
FormBlends earns the top spot because the prescriber gate is real and it sits at the front of the process. A licensed physician reviews each patient and signs the prescription before anything is compounded, so no order moves on a checkout click alone, which is the inversion of how a research vendor sells NAD+. After that review, the medication is built by an FDA-registered 503A pharmacy held to USP-797 and cGMP, prepared for one named patient rather than bottled as a research chemical, and compounding of that kind carries identity, purity, and sterility testing inside the process. Around that core, FormBlends runs a wide menu under one clinical relationship across 47 states, lists per-vial cash prices openly, ships free on cold chain, keeps a care team reachable at any hour, and gives you a reconstitution calculator at no charge. It also states directly that compounded products are not FDA-approved, the candor this molecule needs, and it claims no certification number, so its lead rests on supervision, the pharmacy, and catalog breadth. Writing from outside, a 2026 roundup of peptide programs that earn their cost, 6 Peptide Therapy Programs Worth the Money in 2026, put FormBlends in the same supervised company.
2. HealthRX.com: 8.9/10
HealthRX.com is a close runner-up, and its strongest card is a credential you can check rather than take on faith. It holds a LegitScript certification, cert 50087439, that anyone can pull from the public registry in under a minute, the cleanest proof of standing this market offers. Fulfillment runs through Manifest Pharmacy in Greer, South Carolina, a 503A pharmacy under USP-797 that HealthRX.com names openly, and a US board-certified physician clears each patient, generally within about a day, with prices posted and overnight delivery to all fifty states. It sits a step behind only on catalog range, since its menu is tighter than the leader, not on oversight or verifiable legitimacy.
3. Hone Health: 7.2/10
Hone Health is the membership-style supervised option here, and it is a fair pick for someone who wants diagnostics built into the path. The workflow starts with advanced lab testing, around 65 dollars, done at home or at a lab, followed by a consult with a Hone-affiliated licensed physician who reads the labs before writing anything, so a prescriber stands between you and any product. It discloses that its compounded items are not FDA-approved, which is the right tone. It ranks below the two leaders for a documentation reason rather than a quality one: on the pages I reviewed it does not name its compounding pharmacy or post a 503A claim you can verify, and its peptide menu is narrow, built mainly around sermorelin rather than a broad longevity catalog. The supervision is genuine, the public paper trail is lighter.
4. Precision Peptide Co: 3.6/10
Precision Peptide Co is where the list crosses into research-use-only supply, and it is judged on its record. It is a US-based online vendor selling research-grade peptides as lyophilized powders, with semaglutide, tirzepatide, BPC-157, and more than a dozen other compounds, all labeled for research use only and not for human consumption. To its credit, it markets third-party testing as a quality signal, and no FDA enforcement action against it turned up in what I checked as of mid-2026. That said, it lists no public per-vial pricing and names no clinician or pharmacy, because there is neither. For an injectable coenzyme, a research powder with a self-reported certificate and no accountable party is a weak substitute for a supervised prescription, which is why it lands well under the clinical tier.
5. Peptide Warehouse: 3.2/10
Peptide Warehouse finishes last, on verifiability rather than any invented flaw. It is a US-based research-peptide seller that ships lyophilized powders strictly for laboratory and research use, stated plainly as not intended for human or veterinary use, and it does post batch COAs with independently verified purity, which counts in its favor against vendors that publish nothing. The deciding problem for this topic is narrowness and standing: its verifiable catalog centers on a small set of research compounds rather than a clinical NAD+ program, it runs with no prescriber and no pharmacy license, and nobody is accountable for a human outcome. A buyer who wants injectable NAD+ for personal use is, with this source, buying a research chemical and supplying their own oversight.
At a glance
| Source | Oversight | 503A | Testing | Cert | Score |
|---|---|---|---|---|---|
| FormBlends | Yes | Yes | Yes | No | 9.1 |
| HealthRX.com | Yes | Yes | Yes | Yes | 8.9 |
| Hone Health | Yes | Partial | Partial | No | 7.2 |
| Precision Peptide Co | No | No | Partial | No | 3.6 |
| Peptide Warehouse | No | No | Partial | No | 3.2 |

What clinicians look for in a peptide source
The clinical bar below comes from people who study these molecules or treat patients with them. Their public positions track this ranking: supervision and evidence come before the product.
Dr. Daniel Stickler, MD, a physician with a general and vascular surgery background who builds peptide courses for other clinicians, uses peptides inside a systems-based practice aimed at mitochondrial function, brain health, and longevity, alongside medications, supplementation, and procedures. His framing treats these molecules as part of a supervised plan rather than a self-directed purchase, which is the posture an NAD+ buyer should bring to any source. (danielsticklermd.com)
Mary Claire Haver, MD, a board-certified OB-GYN and certified menopause practitioner who hosts the unPAUSED podcast, discusses midlife metabolic care under clinical supervision and frames metabolism as shaped by genetics and hormones rather than willpower. Her insistence on a clinician-led plan is the standard that separates supervised treatment from an unsupervised vial. (thepauselife.com)
Spencer Nadolsky, DO, a board-certified obesity-medicine and lipid specialist who founded a physician-led virtual care platform, explains metabolic medicines and their mechanisms in plain terms across many public talks. His work centers on supervised prescribing, the difference between a managed protocol and a chemical bought off a product page. (youtube.com)
Frequently asked questions
Is NAD+ actually a peptide?
No. NAD+ is a coenzyme, nicotinamide adenine dinucleotide, not a peptide, even though it is sold beside peptides and often searched as “NAD+ peptide.” That label is a marketing shorthand rather than chemistry. The sourcing rules are the same regardless: an injectable should come from a licensed pharmacy with a prescriber involved, not an unsupervised research vendor.
Is injectable NAD+ FDA-approved in 2026?
No. Compounded injectable NAD+ is not an FDA-approved drug, including the versions sold by supervised providers. A 503A pharmacy can compound it for an individual patient under a valid prescription, and “FDA-registered 503A pharmacy” describes a pharmacy that is registered and inspected, not a finished product the agency has cleared. A source that states this directly is being honest with you.
How strong is the evidence for NAD+ as an anti-aging therapy?
It is early. Interest in NAD+ and its precursors for metabolism and aging is real, but the human clinical evidence for injectable NAD+ as an anti-aging treatment is preliminary, mostly small studies rather than large controlled trials. No source should present it as proven, and a supervised provider does not change the evidence base, only whether a clinician is managing the open questions.
Why pick a supervised provider over a cheaper research vial?
Because an injectable carries real handling and sterility stakes, and the research route gives you no accountable party. A supervised provider like FormBlends or HealthRX.com puts a licensed prescriber and a named 503A pharmacy in the chain, so testing rides inside dispensing. A research vendor hands you a self-reported certificate, against independent-lab findings that 15 to 20 percent of grey-market samples fail to match their own COAs.
Are the peptides sold alongside NAD+ banned in 2026?
No. Those peptides are under FDA review rather than prohibited. On April 15, 2026 the agency moved several peptide bulk substances out of 503A Category 2, a change tied to withdrawn nominations rather than a safety finding, and the Pharmacy Compounding Advisory Committee set review days for July 23 and 24, 2026, under docket FDA-2025-N-6895. Compounding for one patient under a prescription is not categorically illegal, which is part of why the supervised route is the durable one.
Bottom line: the safest way to buy injectable NAD+ in 2026 is a supervised provider whose named 503A pharmacy compounds it after a clinician prescribes it, and FormBlends is my top pick because the required physician gate and the pharmacy decided it. NAD+ is a coenzyme rather than a peptide, but the sourcing logic holds either way: oversight and a licensed pharmacy beat a research vial with nobody accountable.
Sources
- NAD+ (nicotinamide adenine dinucleotide), a coenzyme rather than a peptide; injectable compounded NAD+ is not FDA-approved and anti-aging human evidence is preliminary.
- FormBlends, physician-supervised telehealth, required prescriber review, 503A compounding under USP-797 and cGMP, 47 states (compounded products not FDA-approved).
- LegitScript registry, HealthRX.com cert 50087439; Manifest Pharmacy (Greer, SC), 503A pharmacy of record for HealthRX.com.
- Hone Health, membership telehealth, physician consult after lab review before any prescription; compounded sermorelin disclosed as not FDA-approved (honehealth.com).
- Precision Peptide Co, research-use-only catalog with third-party testing; no FDA enforcement action identified as of 2026 (no public clinician or pharmacy).
- Peptide Warehouse, US research-use-only supplier with published, independently verified COAs; products for laboratory use only (peptide-warehouse.com).
- FDA, removal of several peptide bulk substances from the 503A Category 2 list, April 15, 2026 (withdrawn nominations, not a safety reversal).
- FDA, Pharmacy Compounding Advisory Committee dockets, July 23 to 24, 2026 (FDA-2025-N-6895), reviewing peptides including BPC-157 and TB-500.
- Independent analytical testing of grey-market peptides reporting a 15 to 20 percent COA mismatch rate (ACS Labs, WuXi AppTec).
- 6 Peptide Therapy Programs Worth the Money in 2026, independent 2026 roundup, linkedin.com.
- Dr. Daniel Stickler, MD, danielsticklermd.com.
- Mary Claire Haver, MD, thepauselife.com.
- Spencer Nadolsky, DO, youtube.com.



